Skip to content

Retrospective study of treatment patterns and clinical outcomes in patients with severe tuberculosis

Retrospective study of treatment patterns and clinical outcomes in patients with severe tuberculosis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200065345
Enrollment
Unknown
Registered
2022-11-02
Start date
2022-11-01
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Severe tuberculosis

Interventions

Case series:none

Sponsors

Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 100 Years

Inclusion criteria

Inclusion criteria: Age and gender are not limited; For patients with severe pulmonary tuberculosis, imaging and grading diagnosis meet any of the following criteria: 1. Damaged lung >= 1 lung lobe; 2. Chest CT showed lesions in >= 3 lobes; 3. Hematogenous disseminated pulmonary tuberculosis; 4. Caseous pneumonia; 5. Tuberculosis of bronchus; 6. Multiple hilar or mediastinal lymph nodes were enlarged in primary pulmonary tuberculosis; 7. Rifampicin-resistant, multidrug resistant, multidrug resistant, or pan-drug resistant tuberculosis; 8. Merge at least 2 holes larger than 8mm; 9. Tuberculous massive hemoptysis; 10. Pulmonary tuberculosis with acute infection (including multidrug-resistant bacterial infection, fungal infection or multiple infection); 11. Extrapulmonary tuberculosis (1) Intracranial tuberculosis, spinal cord and/or meningeal tuberculosis; (2) Pleural effusion and pericardial effusion: 1) Empyema or pyopneumothorax, hemopneumothorax, tracheobronchopleural fistula and severe infection; 2) Heart failure due to tamponade or constrictive pericarditis; (3) Multiple sites of lymphatic tuberculosis or surgical treatment is necessary: 1) Cervical lymphatic tuberculosis; 2) Mediastinal lymphatic tuberculosis; 3) Tuberculosis of abdominal or retroperitoneal lymph nodes; (4) Intraperitoneal tuberculosis, tuberculous peritonitis (peritoneal effusion or multiserous effusion): 1) Intestinal tuberculosis causes complete or incomplete intestinal root obstruction or perforation or massive bleeding or severe abdominal infection; 2) Digestive system tuberculosis leads to massive gastrointestinal bleeding, etc; (5) Tuberculosis of musculoskeletal system: 1) Tuberculosis of the spine (neck, chest, waist, sacral vertebrae); 2) Other bones; 3) Complicated with peripheral abscess; (6) Urinary or renal tuberculosis: 1) Renal tuberculosis causes renal failure or bleeding from injured vessels; 2) Ureteral stricture or obstruction due to urinary tuberculosis; (7) Adrenal tuberculosis with adrenocortical hypofunction; (8) The hepatic tuberculosis.

Exclusion criteria

Exclusion criteria: 1. Patients without definite diagnosis at discharge; 2. Patients judged by the investigator to be unsuitable for inclusion in this protocol; 3. Discharged with a diagnosis of central nervous system tuberculosis, or tuberculous meningitis, or tuberculous meningiitis, or tuberculous meningoencephalitis, or tuberculous encephalitis, or tuberculous brain abscess, or spinal tuberculosis, or tuberculous hydrocephalus, and is currently participating in other clinical studies.

Design outcomes

Primary

MeasureTime frame
2-year survival and disability rates;

Countries

China

Contacts

Public ContactQing Ning

Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology

qning@vip.sina.com+86 13971521450

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026